11.03.2013 • NewsSimcere PharmaSimcereChina

Chairman of China's Simcere Pharma Offers Buyout

China-based Simcere Pharmaceutical Group received a buyout offer from a consortium led by founder-chairman Jinsheng Ren for $9.56 per American depositary share (ADS), valuing the company at about $500 million.

The offer represents a premium of 19% to Simcere's Friday close of $8.06. The company's stock was up 14% in premarket trading on Monday.

Simcere, founded in 1995, said on Monday it has formed a special committee of independent directors to consider the proposal.

According to the proposal letter, dated March 11, the potential buyers intend to finance the deal with a combination of debt and equity capital.

If the deal is completed, Simcere, which makes drugs for cancer, and heart and brain diseases, will join a growing list of Chinese companies going private.

Chinese biotechnology firm 3SBio agreed in February to be taken private for about $340 million by a group led by its chief executive and a Chinese private equity firm..

Chinese companies are leaving the U.S. stock markets as government investigations of suspect financial reports and battered share prices have lowered their chances of raising new money in the United States.

Twenty-seven China-based companies with U.S. listings announced plans to go private through buyouts in 2012, up from 16 in 2011 and just six in 2010, according to investment bank Roth Capital Partners.

 

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.